208 related articles for article (PubMed ID: 33579710)
1. Prostaglandin E
Crittenden S; Goepp M; Pollock J; Robb CT; Smyth DJ; Zhou Y; Andrews R; Tyrrell V; Gkikas K; Adima A; O'Connor RA; Davies L; Li XF; Yao HX; Ho GT; Zheng X; Mair A; Vermeren S; Qian BZ; Mole DJ; Gerasimidis K; Schwarze JKJ; Breyer RM; Arends MJ; O'Donnell VB; Iredale JP; Anderton SM; Narumiya S; Maizels RM; Rossi AG; Howie SE; Yao C
Sci Adv; 2021 Feb; 7(7):. PubMed ID: 33579710
[TBL] [Abstract][Full Text] [Related]
2. Prostaglandin E
Goepp M; Crittenden S; Zhou Y; Rossi AG; Narumiya S; Yao C
Immunology; 2021 Dec; 164(4):777-791. PubMed ID: 34529833
[TBL] [Abstract][Full Text] [Related]
3. Prostaglandin E
Li H; Chen HY; Liu WX; Jia XX; Zhang JG; Ma CL; Zhang XJ; Yu F; Cong B
Immunol Lett; 2017 Nov; 191():63-72. PubMed ID: 28963072
[TBL] [Abstract][Full Text] [Related]
4. Prostaglandin E2 regulates Th17 cell differentiation and function through cyclic AMP and EP2/EP4 receptor signaling.
Boniface K; Bak-Jensen KS; Li Y; Blumenschein WM; McGeachy MJ; McClanahan TK; McKenzie BS; Kastelein RA; Cua DJ; de Waal Malefyt R
J Exp Med; 2009 Mar; 206(3):535-48. PubMed ID: 19273625
[TBL] [Abstract][Full Text] [Related]
5. Prostaglandin E2 promotes proliferation of skeletal muscle myoblasts via EP4 receptor activation.
Mo C; Zhao R; Vallejo J; Igwe O; Bonewald L; Wetmore L; Brotto M
Cell Cycle; 2015; 14(10):1507-16. PubMed ID: 25785867
[TBL] [Abstract][Full Text] [Related]
6. E prostanoid 2 (EP2)/EP4-mediated suppression of antigen-specific human T-cell responses by prostaglandin E2.
Okano M; Sugata Y; Fujiwara T; Matsumoto R; Nishibori M; Shimizu K; Maeda M; Kimura Y; Kariya S; Hattori H; Yokoyama M; Kino K; Nishizaki K
Immunology; 2006 Jul; 118(3):343-52. PubMed ID: 16827895
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the EP receptor subtype that mediates the inhibitory effects of prostaglandin E2 on IgE-dependent secretion from human lung mast cells.
Kay LJ; Gilbert M; Pullen N; Skerratt S; Farrington J; Seward EP; Peachell PT
Clin Exp Allergy; 2013 Jul; 43(7):741-51. PubMed ID: 23786281
[TBL] [Abstract][Full Text] [Related]
8. PGE
Thumkeo D; Punyawatthananukool S; Prasongtanakij S; Matsuura R; Arima K; Nie H; Yamamoto R; Aoyama N; Hamaguchi H; Sugahara S; Takeda S; Charoensawan V; Tanaka A; Sakaguchi S; Narumiya S
Cell Rep; 2022 Jun; 39(10):110914. PubMed ID: 35675777
[TBL] [Abstract][Full Text] [Related]
9. Modulation of host natural killer cell functions in breast cancer via prostaglandin E2 receptors EP2 and EP4.
Holt DM; Ma X; Kundu N; Collin PD; Fulton AM
J Immunother; 2012; 35(2):179-88. PubMed ID: 22306906
[TBL] [Abstract][Full Text] [Related]
10. mPGES-1-Mediated Production of PGE
Maseda D; Banerjee A; Johnson EM; Washington MK; Kim H; Lau KS; Crofford LJ
Front Immunol; 2018; 9():2954. PubMed ID: 30619314
[TBL] [Abstract][Full Text] [Related]
11. EP2 and EP4 receptors mediate PGE2 induced relaxation in murine colonic circular muscle: pharmacological characterization.
Martinez-Cutillas M; Mañé N; Gallego D; Jimenez M; Martin MT
Pharmacol Res; 2014 Dec; 90():76-86. PubMed ID: 25461458
[TBL] [Abstract][Full Text] [Related]
12. Direct growth-inhibitory effects of prostaglandin E2 in pancreatic cancer cells in vitro through an EP4/PKA-mediated mechanism.
Schmidt A; Sinnett-Smith J; Young S; Chang HH; Hines OJ; Dawson DW; Rozengurt E; Eibl G
Surgery; 2017 Jun; 161(6):1570-1578. PubMed ID: 28222855
[TBL] [Abstract][Full Text] [Related]
13. T cell-intrinsic prostaglandin E
Lee J; Aoki T; Thumkeo D; Siriwach R; Yao C; Narumiya S
J Allergy Clin Immunol; 2019 Feb; 143(2):631-643. PubMed ID: 29935220
[TBL] [Abstract][Full Text] [Related]
14. Prostaglandin E
Wan M; Tang X; Rekha RS; Muvva SSVJR; Brighenti S; Agerberth B; Haeggström JZ
FASEB J; 2018 May; 32(5):2827-2840. PubMed ID: 29401596
[TBL] [Abstract][Full Text] [Related]
15. Prostaglandin E2 Inhibits NLRP3 Inflammasome Activation through EP4 Receptor and Intracellular Cyclic AMP in Human Macrophages.
Sokolowska M; Chen LY; Liu Y; Martinez-Anton A; Qi HY; Logun C; Alsaaty S; Park YH; Kastner DL; Chae JJ; Shelhamer JH
J Immunol; 2015 Jun; 194(11):5472-5487. PubMed ID: 25917098
[TBL] [Abstract][Full Text] [Related]
16. Dietary tryptophan deficiency promotes gut RORγt
Rankin LC; Kaiser KA; de Los Santos-Alexis K; Park H; Uhlemann AC; Gray DHD; Arpaia N
Cell Rep; 2023 Mar; 42(3):112135. PubMed ID: 36840944
[TBL] [Abstract][Full Text] [Related]
17. Prostaglandin E2 inhibits mast cell-dependent bronchoconstriction in human small airways through the E prostanoid subtype 2 receptor.
Säfholm J; Manson ML; Bood J; Delin I; Orre AC; Bergman P; Al-Ameri M; Dahlén SE; Adner M
J Allergy Clin Immunol; 2015 Nov; 136(5):1232-9.e1. PubMed ID: 25962903
[TBL] [Abstract][Full Text] [Related]
18. Effects of prostaglandin E2 on gene expression in primary osteoblastic cells from prostaglandin receptor knockout mice.
Li X; Pilbeam CC; Pan L; Breyer RM; Raisz LG
Bone; 2002 Apr; 30(4):567-73. PubMed ID: 11934647
[TBL] [Abstract][Full Text] [Related]
19. Prostaglandin E2 signaling through E prostanoid receptor 2 impairs proliferative response of double negative regulatory T cells.
Lee BP; Juvet SC; Zhang L
Int Immunopharmacol; 2009 May; 9(5):534-9. PubMed ID: 19539567
[TBL] [Abstract][Full Text] [Related]
20. Human umbilical cord mesenchymal stem cells improve disease characterization of Sjogren's syndrome in NOD mice through regulation of gut microbiota and Treg/Th17 cellular immunity.
Zou Y; Xiao W; Liu D; Li X; Li L; Peng L; Xiong Y; Gan H; Ren X
Immun Inflamm Dis; 2024 Jan; 12(1):e1139. PubMed ID: 38270310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
